1. Home
  2. FLNG vs AGIO Comparison

FLNG vs AGIO Comparison

Compare FLNG & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FLEX LNG Ltd.

FLNG

FLEX LNG Ltd.

HOLD

Current Price

$29.50

Market Cap

1.6B

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$29.31

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLNG
AGIO
Founded
2006
2007
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
FLNG
AGIO
Price
$29.50
$29.31
Analyst Decision
Hold
Buy
Analyst Count
1
8
Target Price
$23.00
$38.88
AVG Volume (30 Days)
448.5K
750.9K
Earning Date
05-13-2026
04-29-2026
Dividend Yield
9.40%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$43,011,000.00
Revenue This Year
N/A
$76.75
Revenue Next Year
$2.14
$170.73
P/E Ratio
$19.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.72
$22.24
52 Week High
$33.40
$46.00

Technical Indicators

Market Signals
Indicator
FLNG
AGIO
Relative Strength Index (RSI) 32.77 54.44
Support Level $28.62 $26.75
Resistance Level $30.84 $30.90
Average True Range (ATR) 0.82 1.09
MACD -0.35 0.28
Stochastic Oscillator 9.02 64.94

Price Performance

Historical Comparison
FLNG
AGIO

About FLNG FLEX LNG Ltd.

Flex LNG Ltd is an LNG shipping company with a fleet of next-generation LNG carriers with large cargo capacity. The company's fleet consists of several LNG carriers on the water, and all of its vessels are of the latest generation equipped with two-stroke propulsion. Its fleet consists of M-type, Electronically Controlled, Gas Injection (MEGI) LNG carriers and Generation X Dual Fuel (X-DF) LNG carriers, offering improvements in fuel efficiency and thus also carbon footprint compared to the older steam and four-stroke propelled ships. The company has one reportable segment: vessel operations, which generates revenue from the chartering of vessels to customers.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: